Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis
- PMID: 32474042
- PMCID: PMC7255731
- DOI: 10.1016/j.jinf.2020.05.062
Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis
Conflict of interest statement
Declaration of Competing Interest All the authors declare that there are no conflicts of interest.
Figures
Comment in
-
Cancer population may be paradoxically protected from severe manifestations of COVID-19.J Infect. 2020 Aug;81(2):e156-e158. doi: 10.1016/j.jinf.2020.06.011. Epub 2020 Jun 10. J Infect. 2020. PMID: 32534002 Free PMC article. No abstract available.
-
Are COVID-19 susceptibility genes related to lung cancer?J Infect. 2021 Nov;83(5):607-635. doi: 10.1016/j.jinf.2021.08.032. Epub 2021 Aug 23. J Infect. 2021. PMID: 34437926 Free PMC article. No abstract available.
Comment on
-
Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study.J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.04.006. Epub 2020 Apr 14. J Infect. 2020. PMID: 32298677 Free PMC article. No abstract available.
References
-
- Novel Coronavirus Pneumonia Emergency Response Epidemiology The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi= Zhonghua Liuxingbingxue Zazhi. 2020;41(2):145. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical